Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.

AIDS research and human retroviruses - 1 Mar 2002

Schuurman Rob, Brambilla Donald, de Groot Tom, Huang Diana, Land Sally, Bremer James, Benders Ireen, Boucher Charles A B

Abstract excerpt

Current recommendations indicate the use of HIV-1 drug resistance genotyping in the treatment of HIV-1 infection, primarily on treatment failure, and in specific instances also before the initiation of therapy. As such, HIV-1 genotyping is becoming a standard of care parameter in HIV-1 treatment monitoring and a rapidly increasing number of laboratories now use this technology routinely. A study of proficiency,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to HIV/AIDS drug development and treatment

Share to HIV/AIDS Research and Interventions

Share to HIV Research and Treatment

Share to Mutation

Source

Identifiers

PMID: 11860670
DOI: 10.1089/088922202753472801

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.PMID 11860670Read ↗

HIV-1 drug resistance genotyping quality assessment: Results of the ENVA7 Genotyping Proficiency ProgrammeSemantic proximity Read ↗

Results of the 2001 AcroMetrix HIV-1 resistance proficiency program.Semantic proximity Read ↗

Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010Semantic proximity Read ↗

Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results.Semantic proximity Read ↗

Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.Semantic proximity Read ↗

Antiviral resistance testing.Semantic proximity Read ↗

Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.Semantic proximity Read ↗

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges.Semantic proximity Read ↗

Genotypic resistance tests in the management of the HIV-infected patient at virological failure.Semantic proximity Read ↗

Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays.Semantic proximity Read ↗

Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.Semantic proximity Read ↗

Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.